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Abstract
Oversulfated chondroitin sulfate (OSCS), a non-natural sulfated glycosaminoglycan, recognizes as a signiﬁcant
containment in the pharmaceutical heparin, and it could trigger adverse reactions. Chromatography-, electrophoresis-,
electrochemistry-, and spectroscopy-related techniques are currently available for accurate and precise analysis of a trace
amount of OSCS in heparin. Recently, emerging studies focus on developing colorimetric and ﬂuorescent probes to
monitor OSCS containments in heparin. Therefore, this current review aims to describe the sensing principle and
procedure of the reported probes that are sensitive and selective toward OSCS in heparin without the interferences of
other sulfated glycosaminoglycans. The reported OSCS-speciﬁc probes are comprehensively discussed according to the
recognition elements of OSCS, including coralyne, AG73 peptides, positively charged tetraphenylethene derivatives,
polythiophene polymer, and poly-L-lysine, protamine, superpositively charged green ﬂuorescent proteins, and poly
(diallyldimethylammonium chloride). The sensing of OSCS in heparin is generally achieved using, (i) the speciﬁc afﬁnity of the recognition element with OSCS and heparin, (ii) heparinase-mediated hydrolysis of heparin, and (iii) OSCSinduced inhibition of heparinase activity. Additionally, coralyne-based DNA probes can detect OSCS in heparin in the
presence of Ca2þ ions without the assistance of heparinase. This review will pave the way to design another sensing
probe towards other sulfated contaminants, like dermatan sulfate.
Keywords: Colorimetric, Fluorescence, Heparin, Over sulfated chondroitin sulfate, Sensor

1. Introduction

H

eparin is biologically recognized as a unique
polysaccharide with a large number of sulfated
groups, and it is broadly recommended as an anticoagulant drug. After its discovery in 1916 by a
medical student of Johns Hopkins University, the
structure of heparin was identiﬁed to be a building
block based on sugar-containing larger molecules
with different units of combinations such as uronic
acid glucosamine and covalently linked sulfate [1].
These combined units appear to be simple and
make heparin one of the strongest acids of nature.
Heparin is a polydisperse mixture of sulfonated
linear polysaccharides consisting of 75e95% trisulfated disaccharide repeating unit with molecular
weight from 5000 to over 40,000 Da [2]. Later in 1935,
a sufﬁcient amount of pure heparin was launched

for clinical testing to investigate its treatment efﬁciency in preventing postoperative thrombosis.
Inexpensive and well-tolerated heparin-related
therapy efﬁciently controls thrombosis during surgery and anticoagulant therapy and suppresses the
formation of clotting disorders. From then to now,
numerous investigators have been devoted to
establishing different methods for monitoring
plasma heparin since its overdose could lead to
detrimental effects, for example, thrombocytopenia
and hemorrhaging; the therapeutic levels of heparin
are suggested to be 1.7e10 mM for long-term care
and 17e67 mM for cardiovascular surgery. Classical
approaches for quantifying plasma heparin include
the activated partial thromboplastin time (aPTT) the
prothrombin time test [3]. Unfortunately, the abovediscussed approaches have the limitations of inaccurate measurements due to poor speciﬁcity. A
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series of review articles have introduced alternative
techniques to determine heparin in real-world
samples [4,5]. Examples of these techniques include
reversed-phase high-performance liquid chromatography (HPLC), anion-exchange chromatography,
size-exclusion chromatography (SEC), capillary
electrophoresis (CE), polyacrylamide gel electrophoresis (PAGE), nuclear magnetic resonance
(NMR) spectroscopy, and mass spectroscopy.
Although providing accurate and precise quantiﬁcation of heparin, these instrumental methods
require time-consuming operation and skilled
labor. Therefore, developing a portable, sensitive,
selective, and fast-response probe is highly needed
to detect heparin in clinical samples.
In an effort to satisfy this requirement, the investigators have been devoted to the synthesis of
colorimetric and ﬂuorescent sensors toward heparin based on the interplay between the recognition
elements and signal reporters [6]. The reported
recognition elements encompass coralyne [7,8],
surfen [9], AG73 peptides [10], quaternary ammonium moiety-containing molecules [6], protamine
[11], and cationic polymers [12]. Moreover, examples of the recently published reporters include
chromophores [13], ﬂuorophores [14], polymers
[15], metal nanoparticles [16], metal nanoclusters
[17], semiconductor quantum dots [18], phosphorescent molecules [19] and metal-organic framework [20]. Since there have been review articles on
the fabrication of heparin sensors [6,21], the present review article will focus on summarizing the
sensors associated with the detection of a heparinlike glycosaminoglycan, oversulfated chondroitin
sulfate (OSCS). The purity and quality of heparin
drugs related to the presence of OSCS is an
essential issue for the pharmaceutical industry in
order to ensure the safety of the heparin supply.

Contaminated heparin could trigger various undesirable side effects that seem to apply to patients,
such
as
angioedema,
bleeding
complications, hypotension, larynx swelling, and
other related symptoms. These symptoms may
often have ended up in death. For example, in
2008, the administration of contaminated heparin
caused 149 mortality and 574 reports of adverse
reactions in diverse countries [22]. This adverse
effect was identiﬁed as a result of oversulfated
chondroitin sulfate (OSCS), which could be synthesized by sulfonation of low-cost chondroitin
sulfate [2]. The mechanism associated with the
adverse events of OSCS is mainly involved in the
activation of the contact system, triggering the
liberation of bradykinin following an allergic reaction [23]. Review articles have extensively
covered the advancement of mass spectroscopy-,
chromatography-, electrophoresis-, and NMR
spectroscopy-related techniques for the determination of OSCS in heparin drug samples [24,25].
These powerful techniques are capable of detecting heparin with the limits of detection (LODs) of
OSCS in heparin corresponding to 0.1% w/w in
enzyme immunoassay [26], 0.5% w/w in electrochemical detection [27], ~1% w/w in near-infrared
(NIR) spectroscopy [28], 0.2% w/w in PAGE [29],
0.1% w/w in CE [30], and 0.03% w/w in HPLC [31].
However, these published review articles rarely
discuss the existing sensors for rapid analysis of
OSCS in heparin drug samples. Therefore, the
present review article will highlight the recent
advances in the fabrication and applications of
colorimetric and ﬂuorescent sensors toward OSCS
in heparin drug samples. Table 1 summarizes the
recently reported probes for detecting OSCS and
compares them in terms of linear quantiﬁcation
range, LOD, detection mode and response time.

Table 1. The recently reported probes for detecting OSCS in heparin and compares them in terms of linear range, lowest detectable concentration
(LDC), detection mode and analysis time.
Probea

Method

Hepari-nase

Linear range
(% w/w)

LDC
(% w/w)

Detection
mode

Analysis
time

Ref.

TPE-conjugated AG73 peptide
Coralyne-based MB
MnO2 nanosheets, SYBR Green green,
coraylne-based MB, Ca2þ ions
Tb3þ,G-rich ssDNA, AG73 Peptide
Pyrene-labeled GSRKR
PDDA-TPE as AIE nanoassemblies
P4Me-3TOEIM
P4Me-3TOEIM
ScGFP, graphene oxide
ﬂuorophore-modiﬁed heparin-capped AuNPs
ScGFP, rhodaﬂuor dye-labeled heparin

FL
FL
FL

Yes
No
No

1 to 70
0.01 to 20
1010 to 10

1
0.01
1010

Turn ON
Turn ON
Turn ON

4h
5 min
>60 min

33
38
39

RTP
FL
FL
CA
CA
FL
FL
FL

Yes
Yes
No
Yes
Yes
Yes
Yes
Yes

0.002 to 0.2
0.0001 to 1
NA
NA
NA
NA
NA
NA

0.002
0.0001
1
0.003
0.01
10e6
10e9
0.001

Turn ON
Ratio
Turn OFF
Spectral shift
Spectral shift
Turn ON
Turn ON
FRET

80 min
60 min
NA
>30 min
>30 min
>4 h
30 min
>4 h

42
43
49
52
53
55
57
58

a
TPE, tetraphenylethen; G, guanine; MB, molecular beacons; AIE, aggregation-induced emission; ScGFP, superpositively charged green
ﬂuorescent protein; FL, ﬂuorescence; CA colorimetric assay; RTP, room temperature phosphorescence; NA, not available.

2. Challenges for the sensing of OSCS in
heparin
Based on the experience from the design of heparin sensors, the recognition elements used for
heparin are still implemented to integrate with the
signal reporter for the sensing of OSCS in heparin.
The fabrication of OSCS sensors mainly involves: (1)
The electrostatic, hydrogen bonding, and hydrophobic interactions between OSCS and the recognition element; (2) the modiﬁcation of the
recognition unit on the signal reporter or the complex formation of the recognition unit with the
signal reporter; (3) OSCS-stimulated response of the
fabricated sensors. The primary key to sensing
OSCS lies in the selectivity of the recognition
element toward OSCS in the presence of heparin.
However, OSCS has a very similar chemical structure and molecular weight with heparin (Fig. 1) [30];
the difference between OSCS and heparin is the
degree of sulfonation. In other words, the recognition element is incapable of discriminating between
OSCS and heparin without any further assistance.
To overcome this challenge, the investigators have
proposed two strategies to identify OSCS in the
presence of heparin (Fig. 2). One efﬁcient way to
sense OSCS is to combine heparinase digestion with
the proposed sensing system. Without the addition
of OSCS, heparinase can digest heparin into shortfragment glycosaminoglycan. By contrast, the presence of OSCS efﬁciently inhibits the enzymatic activity of heparinase [32], preserving the structure of
heparin. Since the digested heparin exhibits weaker
interaction with the recognition element than the
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undigested heparin, the detection of OSCS could be
successfully achieved using a heparin-related
sensor. The limitations of this strategy include the
cost of heparinase and the reaction time between
heparinase and heparin. The other strategy is to
incorporate Ca2þ ions into the sensing system.
Earlier published results have shown that Ca2þ ions
can speciﬁcally bind to the carboxylate end of the
iduronate unit as well as the N-sulfamido and 6sulfate moieties of the glucosamine unit in heparin
[33,34]. This ﬁnding suggests that the site-speciﬁc
interaction takes place between Ca2þ ions and
heparin in an aqueous solution. Additionally, in
contrast to heparin, OSCS possesses relatively
numerous sulfate moieties. As a result, the proposed
sensing system can exhibit excellent selectivity toward OSCS in heparin drug samples with the
assistance of Ca2þ ions.

3. Recognition elements
The core success of the sensor is mainly determined by selecting suitable recognition elements.
The recognition elements used for heparin are
similar to those applied for OSCS. The published
recognition units that identify OSCS are coralyne,
AG73 peptides, positively charged tetraphenylethene (TPE) derivatives, polythiophene polymer,
poly-L-lysine, protamine, superpositively charged
green ﬂuorescent proteins, and poly (diallyldimethylammonium chloride). The features of
these recognition units are suggested to have a
positively charged structure and a low signal
response for chondroitin sulfate (Chs), hyaluronic


Fig. 1. The structures of major and minor disaccharide repeating units in heparin and OSCS (X ¼ H or SO
3 , Y]COCH3, SO3 , or H). Reproduced
with permission from Ref. [30].
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Fig. 2. Strategies for the determination of OSCS in heparin. (A) Integration of heparinase-mediated digestion of heparin and OSCS-induced inhibition
of heparinase activity into the sensing system. (B) The addition of Ca2þ ions into the sensing system.

acid (HA), and dextran sulfate (DS). In comparison
to other recognition elements, the selectivity of
peptide-based system can be tuned by altering the
peptide sequence. On the other hand, the selection
of the signal reporter could dominate the sensitivity
of the sensing system toward OSCS in heparin.
Since a non-natural OSCS is a principal contaminant in heparin drug samples, the ﬂuorescent reporters could be well-suited to detect trace OSCS in
heparin. We provided a detailed overview of recent
literature associated with OSCS sensors based on
recognizing recognition units.

3.1. Coralyne
Coralyne possesses a planar structure (Fig. 3A)
and speciﬁcally binds to polydeoxyadenosine [poly
(dA)] through the coordination of four adenine
bases with one coralyne. The association constant of
coralyne and poly (dA) was reported to be
1.8  106 M1 [35]. Additionally, coralyne exhibits
strong electrostatic attraction with negatively
charged sulfate glycosaminoglycan, for example,
dextran sulfate and chondroitin-6-sulfate [36]. The
above-discussed features enable the fabrication of

Fig. 3. Schematic illustration of coralyne-based sensors for detecting heparin and OSCS. (A) Chemical structure of coralyne. (B) The A20ecoralyne
complex for ﬂuorescence turn-off detection of heparin through the competitive binding between A20 and heparin for coralyne. Reproduced with
permission from Ref. [7]. (C) The coralyne-based MB as a ﬂuorescent turn-on sensor for heparin through the removal of coralyne from the A20 stem.
Reproduced with permission from Ref. [8]. (D) The coralyne-based MB for sensing OCSCS in heparin based on the use of Ca2þ ions as a masking
agent for heparin. Reproduced with permission from Ref. [37].

the coralyne-polyadenosine (polyA) complex-based
sensors to detect heparin via the interplay of coralyne, polyA, and heparin. For example, Hung et al.
proposed the ﬂuorescent probe based on the direct
mixing of 20-repeat adenosine (A20) and coralyne as
a complex (Fig. 3B) [7]. The complexed coralyne
emitted strong blue ﬂuorescence due to the restriction of its rotation. The presence of heparin was
capable of triggering the removal of coralyne from
the A20-coralyne complexes. As a result, the ﬂuorescence of coralyne was gradually quenched with
increasing the concentration of heparin. Guided by
the same concept, Ku et al. designed an adenosinebased molecular beacon (MB) with a pair of 12-mer
adenosine bases in the stem (Fig. 3C) [8]. The MB
was labeled with a quencher at the 30 -end and a
ﬂuorescent reporter at the 50 -end. Upon the addition
of coralyne interacting with 12-mer adenosine
bases, the structural conformation of the MB was
converted from a random coil to a hairpin. The
conformation change of the MB brought the closeness of a quencher to a ﬂuorophore. By learning
from previous experience in the design of coralynebased sensors toward heparin, Lee et al. found that
the presence of Ca2þ ions allowed an adenosinebased MB to probe 0.01% w/w OSCS in the pharmaceutical heparin within 5 min (Fig. 3D) [37]. The
proposed MB still kept excellent selectivity toward
OSCS when substituting CaCl2 with CaCO3 or
Ca(NO3)2, providing clear evidence associated with
the interaction between Ca2þ ions with heparin.
Similarly, Tian et al. reported the combination of (i)
a hybridization chain reaction of two MBs, (ii) a
coralyne-containing MB that is responsive to heparin and OSCS, (iii) SYBR Green I-adsorbed MnO2
nanosheets, (iv) double stranded-mediated ﬂuorescence enhancement of SYBR Green I, and (v) the use
of Ca2þ ions as an additive for the construction of
the sensing system for OSCS. The proposed sensing
system can detect 108% w/w OSCS in the presence
of heparin [38].
3.2. Peptide
A previous study reported a speciﬁc interaction
between an AG73 peptide and heparin with a
dissociation constant of 6.4 mM [39]. The amino acid
sequence of an AG73 peptide has been determined
to be RKRLQVQLSIRT with an isoelectric point of
12.4. Such kind of peptide owns the pKa values of
12.4 and 10.5 for guanidyl group in an arginine
residue and NHþ
group in a lysine residue,
3
respectively. These positively charged groups
enable an AG73 peptide to have a speciﬁc interaction with glycosaminoglycan-expressed cells. Thus,
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the probe consisting of an AG73 peptide and a reported element is commonly designed to detect
heparin without the interferences of other sulfated
glycosaminoglycans. As an example, You and Tseng
found that an AG73 peptide was capable of triggering the aggregation of glutathione-capped gold
nanoclusters, switching on their luminescence
(Fig. 4A) [10]. The appearance of heparin quenched
the luminescence of the above-discussed aggregates
through the speciﬁc interaction between heparin
and AG73 peptides. The LOD of heparin, detected
by this strategy, was determined to be 3 nM. Cheng
et al. prepared iron-porphyrin derivative-related
metal-organic framework (MOF) nanosheets as a
peroxidase-like nanoenzyme and modiﬁed them
with AG73 peptides through physical adsorption
[40]. The resultant AG73-modiﬁed MOF nanosheets
exhibited low catalytic activity for H2O2-mediated
oxidation of Ampliﬂu Red since AG73 peptides
blocked the active sites. The presence of heparin
restored the catalytic activity of AG73 peptidemodiﬁed MOF nanosheets via the liberation of
AG73 peptides from the MOF nanosheet surface.
The above-discussed probe provided the LOD of
heparin corresponding to 15 ng/mL with a low
response to Chs and HA. Considering that the
chemical properties of OSCS resemble those of
heparin, the investigators have proposed that an
AG73 peptide also has the similar interaction with
OSCS. Ding et al. developed the AG73 peptideconjugated tetraphenylethene probe and showed a
similar ﬂuorescence turn-on response to heparin
and OSCS [32] (Fig. 4B). The introduction of heparin
and OSCS both triggered the aggregation of the
positively charged probe, lighting up the ﬂuorescence of tetraphenylethene resides. This phenomenon is identiﬁed as aggregation-induced emission
(AIE). Once present in the sensing system, heparinase induced the cleavage of heparin. As a result,
the hydrolyzed heparin rarely promoted the aggregation of the AG73 peptide-conjugated probe
without the enhanced ﬂuorescence of tetraphenylethene resides. Given that OSCS can inhibit the
enzymatic activity of heparinase, a mixture of OSCS
and heparin still switched on the ﬂuorescence of the
AG73 peptide-conjugated probe in the presence of
heparinase. Thus, the system mentioned above
could sense a trace amount of OSCS in heparin with
the LOD of 0.001% w/w. Hu et al. reported a timeresolved luminescence (TRL) system for sensitive
and selective detection of OSCS in heparin with the
assistant of heparinase (Fig. 4C) [41]. The sensing
procedure can be divided into four steps: (i) guanine-rich single-stranded DNA (ssDNA) molecules
complex with AG73 peptides through electrostatic
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Fig. 4. Schematic illustration of peptide-related sensors for detecting OSCS and heparin. (A) The nanocomposites of AG73 peptides and glutathionecapped gold nanoclusters as a ﬂuorescent turn-off probe for heparin via the speciﬁc interaction of heparin and AG73 peptides. Reproduced with
permission from Ref. [10]. (B) Fluorescent sensing of OSCS in heparin based on the combination of heparin- and OSCS-induced AIE of AG73
peptide-modiﬁed tetraphenylethene and heparinase-mediated hydrolysis of heparin. Reproduced with permission from Ref. [32]. (C) Fabrication of
the sensing system toward OSCS by the complexation of ssDNA and Tb3þ, electrostatic attraction of ssDNA with AG73 peptides, speciﬁc interaction
of AG73 peptides with OSCS and heparin, and heparinase-mediated digestion of heparin. Reproduced with permission from Ref. [41]. (D) Design of a
ﬂuorescent probe for the detection of OSCS in heparin by heparin-triggered AIE of GSRKR-conjugated pyrene and OSCS-mediated inhibition of
heparinase activity. Reproduced with permission from Ref. [42].

attraction; (ii) Tb3þ ions are introduced into the
formed complexes; (iii) the presence of heparin or
OSCS triggers the release of AG73 peptides from
the complexes, allowing Tb3þ ions to interact with
guanine-rich ssDNA molecules; (iv) the formed
luminescence complexes exhibit strong green
emission since guanine bases behave as an effective
antenna ligand. After heparinase catalyzed the
cleavage of the heparin's saccharide bonds, the hydrolyzed heparin was incapable of activating the
release of AG73 peptides from the complexes. In
other words, the TRL system was insensitive to
heparin in the presence of heparinase. By contrast,
heparinase exhibited low catalytic activity toward
OSCS. Thus, upon the addition of heparinase, the
TRL system was still highly responsive to OSCS,
allowing the detectable concentration as low as
0.002% w/w of OSCS in heparin. In addition to

AG73 peptides, Mehta et al. designed a heparinresponsive peptide (amino acid sequence of
GSRKR) and modiﬁed its tail group with a pyrene
(Fig. 4D) [42]. The arginine units of the proposed
pyrene-modiﬁed peptide were recognized as a
binding site for heparin. Under an excitation
wavelength of 342 nm, the pyrene ﬂuorophore
emitted ﬂuorescence at 396 nm and 480 nm in the
monomer and excimer states. As heparin and OSCS
were added, the as-made peptides were assembled
onto their backbone via electrostatic attraction.
Consequently, the aggregated peptides facilitated
the conjugated pyrene ﬂuorophores to approach
each other, leading to a redshift in their maximum
emission wavelength from 396 to 480 nm. These
features allowed the proposed pyrene-modiﬁed
peptide to sense heparin and OSCS in an aqueous
solution ratiometrically. The above-discussed probe

integrated with heparinase-mediated hydrolysis of
heparin was powerful to detect 0.0001% w/w OSCS
in heparin.
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degree of TPE molecules in the assemblies. The
TPE-PDDA assemblies were substantiated to be
useful in detecting a trace amount of OSCS
contamination in heparin.

3.3. Poly(diallyldimethylammonium) chloride
(PDDA)

3.4. Cationic polythiophene derivatives

A cationic PDDA is well-known to apply various
areas, such as an additive in capillary electrophoresis [43], a polycation in a layer-by-layer technique
[44], and an exfoliating agent in the preparation of
monolayer two-dimensional nanomaterials [45].
Moreover, PDDA can serve as a platform for electrostatic attraction and pp interactions with
negatively charged polyelectrolyte and nanomaterials [46]. In light of these features, Yang et al.
disclosed that PDDA induced the assembly of
negatively charged benzoperylene derivatives (BPD)
through multiple interactions, leading to the conversion of BPD from monomers to excimers [12].
Due to the apparent difference in maximum emission wavelength of BPD between monomers and
excimers, the complexes of PDDA and BPD excimers were implemented for ratiometric sensing of
heparin through the heparin-mediated liberation of
PDDA from the complexes. The as-made complexes
provided accurate and precise quantiﬁcation of
0.4e3.5 mM heparin with the LOD of 50 nM. However, 5 mM Chs could have a higher ratiometric
response than 1 mM heparin. Likewise, Qiao et al.
exploited PDDA to activate the aggregation of sulfonate-ended pyrene, converting their monomers to
excimers [47]. The formed complexes of PDDA and
pyrene derivative excimers were shown to serve as a
ﬂuorescent ratiometric probe for quantifying
0.1e2.3 mM heparin through the restoration of
excimers to monomers. The PDDA-pyrene derivative complexes were highly sensitive to heparin
without the interferences of Chs and HA. Since
complexing with heparin, PDDA polymers are expected to have the same interaction strength with
OSCS. By assembling a PDDA polymer with
carboxyl group-terminated tetraphenylethene (TPE)
molecules, Yang et al. fabricated an AIE-based
sensor to detect heparin and OSCS [48]. The aggregation degree of TPE molecules complexed with
a PDDA polymer can be tuned by simply adjusting
the mixed ratio of TPE to PDDA. The TPE-PDDA
assemblies emitted strong ﬂuorescence at 466 nm,
whereas the added heparin promoted their ﬂuorescence quenching due to the formation of the
PDDA-heparin complexes. A similar result was
observed as OSCS was used in place of heparin. The
sensitivity of the AIE sensor toward heparin and
OSCS was highly connected with the aggregation

Leclerc's group pioneered the synthesis of poly (1methyl-3-[2-[(4-methyl-3-thienyl)oxy]ethyl]-1H-imidazolium) [P4Me-3TOEIM] based on the oxidative
polymerization [49]. The chemical structures of
P4Me-3TOEIM consisting of 4-methyl residue on
each thiophene unit. In the absence of negatively
charged oligomers and polymers, P4Me-3TOEIM
adopts a random coil structure in an aqueous solution, forcing its conjugated backbone to twist in an
aqueous solution and to reduce the effective
conjugation length. By contrast, the introduction of
negatively charged oligomers and polymers can
cause the conformation change of P4Me-3TOEIM
from a random coil structure to a double helix-like
strand. As an outcome, the extended conjugation
length of P4Me-3TOEIM causes a red-shift in its
absorption band. The characteristics mentioned
above inspired the investigators to propose the utilization of P4Me-3TOEIM for the sensing of heparin
through electrostatic attraction. Zhan et al.
employed P4Me-3TOEIM as a colorimetric sensor
for the naked-eye detection of heparin in bovine
serum [50]. The presence of heparin induced the
conformation alternation of P4Me-3TOEIM, and as
a consequence, its maximum absorption wavelength
shifted to a higher value. In other words, the absorption intensity of P4Me-3TOEIM at 500 nm was
gradually enhanced with increasing the heparin
concentration. The LODs of heparin in water and
bovine serum obtained from P4Me-3TOEIM were
reported to be 0.01 and 0.15 U/mL, respectively.
Sommers and Keire took the advantages of P4Me3TOEIM to design a convenient probe for the
naked-eye sensing of OSCS in heparin based on (i)
OSCS-mediated inhibition of heparinase I and II
activity and (ii) the digested heparin-induced color
change of P4Me-3TOEIM [51]. It was found that
P4Me-3TOEIM exhibited a higher colorimetric
response to dermatan sulfate and Chs (partially
sulfated form) than OSCS and heparin (oversulfated
form). Accordingly, the selectivity of P4Me-3TOEIM
could be dominated by the tertiary structure of
sulfated glycosaminoglycans rather than their sulfation degree. As OSCS inhibited heparinase activity, the undigested heparin only caused a slight
color change of P4Me-3TOEIM. The P4Me-3TOEIM
probe successfully detected 0.003% w/w in heparin
sodium active pharmaceutical ingredient and 0.1%
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w/w in the crude heparin samples. The same group
disclosed that the absorption band of P4Me3TOEIM is susceptible to the molecular weight of
heparin [52]. The P4Me-3TOEIM probe, relying on
the same sensing mechanism, was employed to
identify 0.01% w/w OSCS in commercially available
low-molecular-weight
heparin
(M.W.
ca.
4000e6000), such as enoxaparin, dalteparin, and
tinzaparin. Dermatan sulfate and Chs have been
recognized as contaminants in heparin drug samples. Toby et al. integrated the P4Me-3TOEIM probe
with chondroitinase digestion and centrifugal
ﬁltration to analyze dermatan sulfate and Chs in
heparin [53]. The role of chondroitinase is to cleavage chondroitins, while the functionality of centrifugal ﬁltration is to separate a mixture of digested
chondroitins and heparin. This sensing system was
feasible for monitoring 0.5% w/w dermatan sulfate
and 1.0% w/w Chis in heparin.
3.5. Fluorescent proteins
Superpositively charged green ﬂuorescent
proteins (ScGFPs) were introduced for the
sensing of heparin due to their distinct

advantages of satisfactory biocompatibility, good
water solubility, and numerous positively
charged groups (a net charge of þ36). It is expected that ScGFPs could strongly bind to heparin via electrostatic attraction and hydrophobic
interaction. According to these features, Wang
et al. developed a ﬂuorescence turn-on probe for
selective detection of OSCS in heparinasetreated heparin [54]. The sensing mechanism
mainly involved the following concepts (Fig. 5A):
(i) superpostively charged ScGFPs were electrostatically assembled on the surface of graphene
oxide, quenching their ﬂuorescence based on
energy or charge transfer; (ii) superpostively
charged ScGFPs electrostatically interact with
heparin without the interference of their ﬂuorescence; (iii) the complexes of ScGFPs and
heparin were rarely adsorbed on the surface of
graphene oxide due to electrostatic repulsion
between them; (iv) OSCS inhibited the digestion
of heparin by heparinase. By the interplay
among of ScGFPs, graphene oxides, and heparinase, the sensing system was capable of
quantifying 3.3e66.7 nM heparin in 10% human
plasma and 109 to 10% w/w OSCS in heparin.

Fig. 5. (A) Fluorescent sensing of OSCS in heparin based on graphene oxide-induced ﬂuorescence quenching of ScGFP, heparin-promoted removal of
ScGFP from graphene oxide, and OSCS-mediated suppression of heparinase activity. Reproduced with permission from Ref. [54] (B) Modiﬁcation of
heparin with thiol groups and ﬂuorophores, followed by the conjugation to the surface of citrate-capped AuNPs. Reproduced with permission from
Ref. [56].

3.6. Organic dye-labeled heparin
It is well-documented that heparinase speciﬁcally
cleaves heparin, and its activity is inhibited by
OSCS [32,55]. According to this information, Kalita
et al. modiﬁed heparin with thiol groups and HiLyte
Fluor 594 ﬂuorophores, resulting in thiol- and
HiLyte Fluor production 594-conjugated heparin
[56]. Subsequently, the thiol- and HiLyte Fluor 594conjugated heparin was directly attached to the
surface of citrate-capped gold nanoparticles
(AuNPs) through the formation of AueS bonds
(Fig. 5B). The ﬂuorescence of the conjugated HiLyte
Fluor 594 in heparin was efﬁciently quenched by the
AuNPs as a result of nanometal surface energy
transfer. The presence of heparinase digested the
adsorbed heparin, leading to the release of HiLyte
Fluor 594 from the nanoparticle surface. By contrast,
the added OSCS blocked heparinase activity, suppressing the liberation of HiLyte Fluor 594. Taken
together, the ﬂuorescence of the conjugated HiLyte
Fluor 594 was progressively reduced with increasing
the concentration of OSCS in heparin. This sensing
platform identiﬁed 109% w/w OSCS in heparin
within 30 min. Additionally, Ding et al. fabricated
the complexes of ScGFPs and rhodaﬂuor dyelabeled heparin [57]. The ﬂuorescence resonance
energy transfer (FRET) occurred from ScGFPs to
rhodaﬂuor dye-labeled heparin in the formed
complexes due to the spectral overlap between the
emission of ScGFPs and the absorption of rhodaﬂuor dye. Heparinase was introduced to cleavage
rhodaﬂuor dye-labeled heparin in the formed
complexes, producing free rhodaﬂuor dye-labeled
heparin fragments without complexing with
ScGFPs. In other words, a FRET efﬁciency between
ScGFPs and rhodaﬂuor dye-labeled heparin was
inversely dependent on the level of heparinase;
however, OSCS blocked the phenomenon
mentioned above. The combination of heparinase
and the as-made complexes was well-suited for
ratiometric sensing of 0.001% w/w OSCS in heparin.

4. Conclusion and future trends
Most of the probes mentioned above are highly
involved in heparinase treatment owing to the high
speciﬁcity of heparinase toward heparin and OSCSinduced inhibition of its activity. However, this
strategy could have some limitations: (i) heparinase
activity is sensitive to environmental variations,
such as pH and temperature; (ii) heparinase takes a
long time to digest heparin (>1 h); (iii) expensive
heparinase requires temperature and humidity
controls; (iv) the prolong incubation of OSCS with
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heparinase is needed to block its activity. Hence, we
recommend that the challenge in this ﬁeld will be to
develop the probe for rapid sensing of OSCS in the
absence of heparinase. On the other hand, the most
common contaminant in heparin is known as dermatan sulfate. The level of dermatan sulfate is
determined to be 1e7% in heparin. Since dermatan
sulfate rarely affects the anticoagulation outcome of
heparin, the investigator barely focuses on developing the sensor toward dermatan sulfate. However, the United States Pharmacopoeia (USP)
recommended that the level of dermatan sulfate
impurities should be lower than 1% in heparin. The
building blocks of dermatan sulfate comprise four
possible hexosamines and three possible uronic
acids. Dermatan sulfate contains speciﬁc iduronic
acid, which is effective in distinguishing it from
heparan sulfate and heparin. However, unlike
OSCS and heparin, dermatan sulfate holds a relatively low negative charge. Accordingly, it is another
challenge to rationally design a suitable probe for
dermatan sulfate without heparin interference.
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